Wednesday, September 23, 2009

Priceless: Two Items from the GlaxoSmithKline PR Spin Machine

Item #1: From the GSK "Frequently Asked Questions" page:

Does GSK fund CME programs in order to influence doctors and get them to prescribe your medicine?

No, not at all. GSK is committed to supporting quality healthcare education. Our goal is to support independent medical education programs for healthcare professionals (physicians, nurses, pharmacists and other healthcare professionals) to increase their knowledge, competence, performance and ultimately improve patient outcomes. Doctors and other healthcare professionals must take CME/CE courses to maintain their licenses and hospital privileges. The Accreditation Council for CME (ACCME), Accreditation Council for Pharmacy Education (ACPE), American Nurses Credentialing Center (ANCC) and others set accreditation criteria for the programs to physicians, pharmacists, nurses and other healthcare professionals. It is also important to note that GSK does not control the content of independent educational programs and that the purpose of the programs is not to promote GSK products.

Item #2: The URL of the GSK web page for organizations seeking CME grants:



BipolarPorch said...

I just love what you are doing Dr. Carlat. When I get some money I am going to get your actual newsletter. Disabled presently, but I will get it when my ship comes in!!

Visit my Bipolar News Site...

Anonymous said...

PR, PR, PR...Actually, it was edited to "No, not at all" from "Of course we did, but we got caught" and from "we did control content and to promote our products and got caught doing that too" to what it now reads. They just state exactly what they have done wrong with what they publish as PR. Has anyone checked out the PR on adverse events? Hilarious, just follow the PR changes in their website. The PR guy should be fired for making it sooo obvious. What they term "transparency" is what was previously hidden from view. Get the idea? Pharma is funny like that, just track it, and dig further, bound to find out more than was disclosed.